Invention Grant
- Patent Title: LSD1 inhibitors
-
Application No.: US15725949Application Date: 2017-10-05
-
Publication No.: US10233152B2Publication Date: 2019-03-19
- Inventor: Matthew Arnold Marx , Arkadii Vaisburg , James Gail Christensen , Robert Anthony Galemmo, Jr.
- Applicant: Mirati Therapeutics, Inc.
- Applicant Address: US CA San Diego
- Assignee: MIRATI THERAPEUTICS, INC.
- Current Assignee: MIRATI THERAPEUTICS, INC.
- Current Assignee Address: US CA San Diego
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Main IPC: C07D211/58
- IPC: C07D211/58 ; C07D205/04 ; C07D211/76 ; C07D211/88 ; C07D221/22 ; C07D401/12 ; C07D413/12 ; C07D413/14 ; C07D417/12 ; C07D265/10 ; C07D213/64
Abstract:
The present invention relates to compounds that inhibit LSD1 activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.
Public/Granted literature
- US20180127369A1 LSD1 Inhibitors Public/Granted day:2018-05-10
Information query
